Effects of Fufang Biejia Ruangan Pills on hepatic fibrosis in vivo and in vitro

Table 1 Effect of Fufang Biejia Ruangan Pill on serum levels (mean ± SD)

Group	ALT(U/L)	AST(U/L)	PCIII (μg/mL)	HA (ng/mL)	LN (ng/mL)	CIV (ng/mL)
Control	23.8 ± 8.5b	30.0 ± 11.4b	15.16 ± 15.12b	205.30 ± 48.92a	82.02 ± 8.86	21.71 ± 1.76
Model	62.0 ± 23.7	98.8 ± 40.0	35.73 ± 17.90	563.82 ± 335.54	89.57 ± 7.59	29.20 ± 6.17
FFBJRGP-treated	50.02 ± 3.7	57.2 ± 30.0b	30.18 ± 9.41	456.18 ± 410.83	85.46 ± 7.51	28.02 ± 9.45
Colchicine-treated	46.1 ± 14.8	66.0 ± 33.2a	34.08 ± 9.19	313.17 ± 230.06a	88.61 ± 8.97	29.22 ± 7.95

^aP < 0.05,

^bP < 0.01 vs model group. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; PCIII: Type III procollagen; HA: Hyaluronic acid; LN: Laminin; CIV: Type IV collagen; FFBJRGP: Fufang Biejia Ruangan Pill.